Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial

ConclusionsIn patients with severe submassive PE, inhaled nitric oxide failed to increase the proportion of patients with a normal troponin and echocardiogram but increased the probability of eliminating RV hypokinesis and dilation on echocardiography.Clinical trial registrationNCT01939301.
Source: Nitric Oxide - Category: Chemistry Source Type: research